NEW YORK, April 8, 2016 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN).
The investigation focuses on whether the Company and its executives violated federal securities laws by making false statements regarding and/or failing to disclose the commercial viability of its main product, the osteoporosis drug program ZP-PTH, in connection with the Company's January 27, 2015 Initial Public Offering ("IPO").
Specifically, in January 2015, Zosano offered more than 6,500,000 shares of its common stock at $11.00 per share in connection with its IPO. Fifteen months later, however, Zosano common stock has declined and was trading at just $2.26 per share during intra-day trading on April 8, 2016 – a 79.5% drop from its IPO price.
Request more information now by clicking here: www.faruqilaw.com/ZSAN. There is no cost or obligation to you.
If you invested in Zosano stocks or options and would like to discuss your legal rights, visit www.faruqilaw.com/ZSAN. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Zosano's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/zosano-notification-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-zosano-pharma-corporation-to-contact-the-firm-300248715.html
SOURCE Faruqi & Faruqi, LLP